• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza virus activity in the world, 13 September 2013 (WHO, edited): Wks 34-35/13, H3N2 predominant strain

Giuseppe

Emeritus
[Source: World Health Organization, full page: (LINK). Edited.]


Influenza virus activity in the world, 13 September 2013

Source: Laboratory confirmed data from the Global Influenza Surveillance and Response System (GISRS).
____

Based on FluNet reporting (as of 10 September 2013, 08:45 UTC), during weeks 34 to 35 (18 August 2013 to 31 August 2013), National Influenza Centres (NICs) and other national influenza laboratories from 69 countries, areas or territories reported data. The WHO GISRS laboratories tested more than 21 167 specimens. 1546 were positive for influenza viruses, of which 1295 (83.8%) were typed as influenza A and 251 (16.2%) as influenza B. Of the sub-typed influenza A viruses, 500 (46.4%) were influenza A(H1N1)pdm09, 576 (53.5%) were influenza A(H3N2) and 1 (0.1%) was influenza A(H3N2)v. Of the characterized B viruses, 20 (87%) belong to the B-Yamagata lineage and 3 (13%) to the B-Victoria lineage.


Summary

During weeks 34 and 35, global influenza activity remained low. (H3N2) viruses were the predominant virus detected followed by A(H1N1)pdm09 and influenza B viruses.

In Oceania, influenza A(H1N1)pdm09 virus activity increased in Australia and co-circulated with A(H3N2) viruses, while influenza A(H3N2) and B activity remained high in New Zealand.

In Africa, A(H3N2) and influenza B viruses co-circulated throughout the region. Increased influenza B activity was reported from the Central African Republic while A(H3N2) remained predominant in South Africa.

Influenza virus activity was low in Asia. A(H3N2) virus was predominant in China and Thailand and co-circulated with A(H1N1)pdm09 virus in India.

In Central and South America, all three virus types were detected and co-circulated in varying proportions. A(H3N2) virus remained predominant in Cuba while A(H1N1)pdm09 was the most frequently detected virus in Ecuador.

Influenza activity remained low in the Europe and North America.

Click here for avian influenza A(H7N9) situation updates, risk assessment and other technical information

Click here for information from the Centers for Disease Control and Prevention (CDC), United States of America, about A(H3N2)v infections


-
------
 
Back
Top